Congratulations to the NIDA labs who participated and received awards in the 2023 NIH Green Labs Program! Molecular Neuropsychiatry Section, Adjei, Nasser – Gold Translational Analytical Core, Kryszak, Lindsay – Silver Neuronal Circuits and Behavior Section, Sarsfield, Sarah – Silver Integrative Neuroscience Research Branch, Neuronal Networks Section, Barbano, Flavia – Bronze Molecular Targets and Medications… [Read More]
Hot Off the Press
Incubation of methamphetamine craving in punishment-resistant individuals is associated with activation of specific gene networks in the rat dorsal striatum
Hot Off the Press – April 24, 2024 Published in Molecular Psychiatry by Atul Daiwile and Jean Lud Cadet, et al. from the NIDA IRP Molecular Neuropsychiatry Section. Summary Methamphetamine also called METH, crank, ice etc. is a powerful stimulant that has caused addiction in a lot of people in the world. Humans who take… [Read More]
Reviews To Read
Relapse after electric barrier-induced voluntary abstinence: A review
Reviews To Read – April 2024. Published in Current Opinion in Neurobiology by Kenichiro Negishi and Yavin Shaham of the NIDA IRP Neurobiology of Relapse Section. In this review we introduce the electric barrier conflict model of drug relapse and review studies on behavioral and neuropharmacological mechanisms of cue-induced relapse and incubation of drug seeking (time-dependent… [Read More]
Featured Papers
Catecholaminergic Modulation of Large-Scale Network Dynamics Is Tied to the Reconfiguration of Corticostriatal Connectivity
Featured Paper of the Month – March 2025
Published in Human Brain Mapping by Justine Hill and Amy Janes, et al. of the NIDA IRP Cognitive and Pharmacological Neuroimaging Unit.
In this study, we show that methylphenidate – a drug used to treat ADHD by increasing dopamine and norepinephrine – boosts the amount of time that the brain is engaged in both internal and external attention networks.
